Screening the
unscreenable

We record molecular binding directly into DNA

ABOUT US

The most valuable medicines bring 
proteins together

Molecular glues and protein–protein interaction stabilizers have produced some of the most important therapies in oncology and immunology. They work by inducing proximity: holding two proteins in a productive embrace. Outside of biologics, nearly every example has been found by accident or through derivatization of natural products. The bottleneck isn’t biology or clinical translation — it’s the inability to intentionally screen for glues at scale.

At Delphini, we use the DELSTAR™ platform and utilize the power of DNA encoded libraries and proximity induced technology to permanently encode a binding event between two targets into the DNA … to find molecules that induce proximity between the targets.

Meet the team

Dennis Gillingham

Chairman and Co-Founder

Lukas Schneider

Scientist and Co-Founder

Basilius Sauter

Data Scientist and Co-Founder

News

Delphini Therapeutics AG was founded